Cargando…
COVID-19 Presenting as Recurrent Pericardial Effusion
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) emerged from Wuhan, China, in 2019, causing coronavirus disease 19 (COVID-19) and creating a global pandemic affecting millions of people worldwide. Though COVID-19 primarily affects the pulmonary structures, deleterious effects can also occ...
Autores principales: | Tran, Dena H, Gupta, Anuj, Verceles, Avelino C, Chow, Robert D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509094/ https://www.ncbi.nlm.nih.gov/pubmed/34659927 http://dx.doi.org/10.7759/cureus.18652 |
Ejemplares similares
-
Lamotrigine-Induced Lupus With Aseptic Meningitis and Hemophagocytic Lymphohistiocytosis
por: Tran, Dena H, et al.
Publicado: (2022) -
Antipsychotic Medication-Induced Hyperthermia Leading to Cerebrovascular Accident: A Case Report
por: Best, Karimah, et al.
Publicado: (2021) -
Acute Pericarditis and Pericardial Effusion in a Hypertensive COVID-19 Patient
por: Naqvi, Syeda Ghadeer Zehra, et al.
Publicado: (2020) -
A Rare First Presentation of Hodgkin's Lymphoma: Symptomatic Pericardial Effusion
por: Matos Sousa, Rita, et al.
Publicado: (2023) -
Minoxidil-Induced Pleuro-Pericardial Effusion With Tamponade
por: Akinleye, Akintayo, et al.
Publicado: (2023)